Identification
Please complete the identification section. Fields
marked with an asterisk* are required.
Are
you a (check
all that apply)
|
Is
this your first comment on "Population-based
Prenatal Screening for Cystic Fibrosis via Carrier Testing?"
General Evaluation
1. How
worthwhile was this document to you?
|
2. How
useful will this document be to you in your work?
|
3. How
does the information contained in this document compare to what you have
used in the past?
|
4. How
does the process (described in the Introduction) compare to what
you have
used in the past to evaluate clinical
test performance?
|
5. Did
you have any problems downloading this document?
|
6. Which
sections did you read/review?
|
7.
Comments
Please specify the page numbers that pertain to
your comments (e.g., 2-11 through 2-13). You may
enter text directly or paste from another document in the box
below. When the form is completed, click submit.
If you prefer, you may compose your
comments in a word processing document (preferably in WORD
format). Be sure to include your name and e-mail address as well
as the document title and the page numbers you are evaluating
(e.g., 2-11 through 2-13). Send an e-mail with the word document
attached to accecomments@FBR.org
Please be as specific as possible and
include both positive and negative comments. We thank you for your
participation. |
|